To identify genetic alterations with a potential functional relevance for the activity of AP-1 in RA, the occurrence of mutations and/or SNPs in the coding regions of fos and jun family members was initially assessed in (c)DNA samples from a limited number of affected patients. This evidence concerns the gene FOS and rheumatoid arthritis.